Prognostic importance of a second invasive primary melanoma according to tumor stage.
AffiliationCancer Council Queensland, Brisbane, Queensland, Australia
MetadataShow full item record
AbstractIt is well known that a considerable proportion of the Caucasian population in many countries are diagnosed with multiple melanomas over time(1) . Despite this, most analyses of melanoma survival, including that of the American Joint Committee on Cancer (AJCC), consider only one tumor for every patient and disregard the potential effect of multiple melanomas on outcomes and this is reflected in the lack of specific management guidelines for patients with multiple melanomas beyond those dictated by the clinicopathological features of each tumour(2-4) . Recently we and others have shown that patients with multiple primary invasive melanomas have an increased risk of melanoma death compared to patients with a single melanoma(5,6) . This article is protected by copyright. All rights reserved.
CitationPrognostic importance of a second invasive primary melanoma according to tumor stage. 2017 Br. J. Dermatol.
JournalThe British Journal of Dermatology
- Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.
- Authors: Youlden DR, Khosrotehrani K, Green AC, Soyer HP, Kimlin MG, Youl PH, Aitken JF, Baade PD
- Issue date: 2016 Feb
- Survival outcomes in patients with multiple primary melanomas.
- Authors: Rowe CJ, Law MH, Palmer JM, MacGregor S, Hayward NK, Khosrotehrani K
- Issue date: 2015 Nov
- Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
- Authors: Youlden DR, Baade PD, Soyer HP, Youl PH, Kimlin MG, Aitken JF, Green AC, Khosrotehrani K
- Issue date: 2016 Nov
- Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
- Authors: Green AC, Baade P, Coory M, Aitken JF, Smithers M
- Issue date: 2012 May 1
- Melanoma survival is superior in females across all tumour stages but is influenced by age.
- Authors: Khosrotehrani K, Dasgupta P, Byrom L, Youlden DR, Baade PD, Green AC
- Issue date: 2015 Oct